Hemifacial Myokymia as the Presenting Feature of Multiple Sclerosis

Authors

DOI:

https://doi.org/10.46531/sinapse/CC/220062/2022

Keywords:

Demyelinating Diseases/ diagnostic imaging, Facial Nerve Diseases/ diagnostic imaging, Multiple Sclerosis/diagnosis

Abstract

The clinical presentation of multiple sclerosis (MS) is variable and can pose a diagnostic challenge. A case of unilateral perioral myokymia as the revealing feature of MS is reported. We present the case of a 43-year-old male, observed in our outpatient clinic with a two-week history of continuous involuntary wavelike movement across the left side of his face. Neurological examination revealed left-sided facial myokymia with perioral involvement and hemifacial spasm. Brain magnetic resonance imaging (MRI) showed multiple white matter hyperintensities on T2/FLAIR, suggestive of demyelination, involving periventricular, juxta-cortical regions, and the corpus callosum. Cerebrospinal fluid (CSF) analysis showed CSF-specific oligoclonal bands. The diagnosis of relapsing-remitting multiple sclerosis was made according to the McDonald Criteria from 2017. This case illustrates an unusual presentation of MS and highlights the importance of awareness of possible MS in young adults with facial myokymia, more so when continuous and with perioral involvement.

Downloads

Download data is not yet available.

References

Marin Collazo IV, Tobin WO. Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes. Neurologist. 2018;23:1-6. doi: 10.1097/NRL.0000000000000163.

London F, Hadhoum N, Zéphir H, Vermersch P, Outteryck O. Continuous hemifacial myokymia as the revealing symptom of demyelinating disease of the CNS. Mult Scler Relat Disord. 2017;11:10-11. doi: 10.1016/j.msard.2016.11.001.

Parr AC, Bashford J, Silber E. Facial myokymia as the presenting feature of multiple sclerosis. Pract Neurol. 2022;22:233-4. doi: 10.1136/practneurol-2021-003268.

Etemadifar M, Sabouri M, Zarepour M, Akhavan Sigari A, Salari M. Facial involvement in multiple sclerosis. Mult Scler Relat Disord. 2022;67:104110. doi: 10.1016/j. msard.2022.104110.

Ghosh R, Roy D, Dubey S, Das S, Benito-León J. Movement Disorders in Multiple Sclerosis: An Update. Tremor Other Hyperkinet Mov. 2022;12:14. doi: 10.5334/tohm.671.

Sharma RR, Mathad NV, Joshi DN, Mazarelo TB, Vaidya MM. Persistent facial myokymia: a rare pathognomic physical sign of intrinsic brain-stem lesions: report of 2 cases and review of literature. J Postgrad Med. 1992;38:37-40, 40A-40B.

Jacobs L, Kaba S, Pullicino P. The lesion causing continuous facial myokymia in multiple sclerosis. Arch Neurol. 1994;51:1115-9. doi: 10.1001/archneur.1994.00540230053012.

Palasí A, Martínez-Sánchez N, Bau L, Campdelacreu J. Unilateral eyelid myokymia as a form of presentation of multiple sclerosis. Neurologia. 2013;28:187-9. doi: 10.1016/j. nrl.2011.09.010.

Hertz R, Espinosa J, Lucerna A, Stranges D. Multiple Sclerosis Presenting with Facial Twitching (Myokymia and Hemifacial Spasms). Case Rep Neurol Med. 2017;2017:7180560. doi: 10.1155/2017/7180560.

Dupeyron A, Chaury F, Guiraud-Chaumeil C, Tranchant C. Hémicontracture et myokimies faciales continues révélatrices d’une sclérose en plaques. Rev Neurol. 2001;157:315-7.

Clay JL, Villamar MF. Continuous facial myokymia in multiple sclerosis. Clin Case Rep. 2020;8:2326-7. doi: 10.1002/ ccr3.3135.

Salavisa M, Serrazina F, Pires P, Correia AS. Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia. Neurology. 2021;97:e111-2. doi: 10.1212/WNL.0000000000012052.

Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002;15:239-45. doi: 10.1097/00019052-200206000-00003.

Sedano MJ, Trejo JM, Macarrón JL, Polo JM, Berciano J, Calleja J. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin. Eur Neurol. 2000;43:137-40. doi: 10.1159/000008152.

Habek M, Adamec I, Gabelic T, Brinar VV. Treatment of facial myokymia in multiple sclerosis with botulinum toxin. Acta Neurol Belg. 2012;112:423-4. doi: 10.1007/s13760-012-0092-3.

Downloads

Published

2024-04-20

How to Cite

1.
Magriço M, Serrazina F, Freire I, Viana Baptista M. Hemifacial Myokymia as the Presenting Feature of Multiple Sclerosis. Sinapse [Internet]. 2024 Apr. 20 [cited 2024 Jul. 15];22(4):179-81. Available from: https://sinapse.pt/index.php/journal/article/view/53